Merit Medical Systems (Nasdaq:MMSI) announced that its application for reimbursement for its Wrapsody procedures requires further CMS consideration. As a result, the company plans to go ahead with the U.S. rollout for the cell-impermeable endoprosthesis (CIE). "We have elected to withdraw our application for TPT incremental payment and intend … [Read more...] about Merit Medical to launch Wrapsody endoprosthesis in U.S. after CMS defers reimbursement decision
Merit Medical
Merit Medical to acquire cryoballoon tech from Pentax
Merit Medical Systems (Nasdaq:MMSI) announced an agreement to acquire the C2 CryoBalloon device from a Pentax Medical subsidiary. South Jordan, Utah-based Merit signed a definitive asset purchase agreement with Pentax of America over the C2 CryoBalloon and related technology. The companies expect the closing of the deal to occur during the fourth … [Read more...] about Merit Medical to acquire cryoballoon tech from Pentax
First patient enrolled in Merit Medical Wrapsody endoprosthesis registry
Merit Medical Systems (Nasdaq:MMSI) announced today that it enrolled the first patient in the WRAP North America registry. WRAP evaluates the company's Wrapsody cell-impermeable endoprosthesis (CIE), which the FDA approved last December. South Jordan, Utah-based Merit designed Wrapsody to extend long-term vessel patency in dialysis patients. It … [Read more...] about First patient enrolled in Merit Medical Wrapsody endoprosthesis registry
Merit Medical launches aortic access delivery system
Merit Medical Systems (Nasdaq:MMSI) announced that it launched the Ventrax delivery system for cardiac interventions. South Jordan, Utah-based Merit adds the latest delivery system to its growing electrophysiology (EP) and cardiac rhythm management (CRM) portfolio. It joins solutions such as HeartSpan, Worley, Prelude Snap and SafeGuard … [Read more...] about Merit Medical launches aortic access delivery system
FDA approves Merit Medical’s cell-impermeable endoprosthesis
Merit Medical Systems (Nasdaq:MMSI) announced today that it received FDA premarket approval for its Wrapsody cell-impermeable endoprosthesis. With approval, the company can begin commercializing the device in the U.S. in 2025. South Jordan, Utah–based Merit Medical designed Wrapsody to extend long-term vessel patency in dialysis patients. It … [Read more...] about FDA approves Merit Medical’s cell-impermeable endoprosthesis
Merit Medical completes acquisition of Cook Medical’s lead management portfolio
Merit Medical Systems (Nasdaq:MMSI) announced today that it completed its acquisition of Cook Medical’s lead management portfolio. South Jordan, Utah-based Merit announced its agreement to buy the portfolio for $210 million in September. Merit funded the acquisition through a combination of cash on hand and borrowings under a long-term credit … [Read more...] about Merit Medical completes acquisition of Cook Medical’s lead management portfolio
Merit Medical to buy Cook Medical’s lead management portfolio
Merit Medical Systems (Nasdaq:MMSI) announced today that it agreed to acquire Cook Medical's lead management portfolio for $210 million. Cook Medical's lead management business provides medical devices and accessories used in lead management procedures. These procedures occur in patients who need a pacemaker or an implantable … [Read more...] about Merit Medical to buy Cook Medical’s lead management portfolio
Merit Medical launches expanded Maestro microcatheter line
Merit Medical Systems this week announced the launch of its expanded Maestro microcatheter product line. The Maestro product line features embolotherapy devices, which include Embosphere Microspheres. The new 165 cm Maestro length will be available in 2.1F, 2.4F, 2.8F and 2.9F catheter diameters to support a broad range of embolization … [Read more...] about Merit Medical launches expanded Maestro microcatheter line
Merit Medical spends $132.5M on acquisitions to expand its offerings
AngioDynamics (Nasdaq:ANGO) announced that it completed the sale of its dialysis product portfolio to Merit Medical Systems. It was part of a series of product acquisitions worth $132.5 million that Merit (Nasdaq: MMSI) has announced. Latham, New York-based AngioDynamics sold its dialysis portfolio and the BioSentry product for $100 million … [Read more...] about Merit Medical spends $132.5M on acquisitions to expand its offerings
Merit Medical launches new Prelude Roadster guide sheath
Merit Medical Systems (Nasdaq:MMSI) announced today that it commercially released its Prelude Roadster guide sheath. South Jordan, Utah-based Merit designed its Prelude Roadster for deliverability, visibility, and resilience in tortuous peripheral vasculature anatomies. It helps to deliver devices used to diagnose and treat patients with … [Read more...] about Merit Medical launches new Prelude Roadster guide sheath
